Our take on Avidity's FORTITUDE phase 1/2 trial data
Jun 11, 2025•55 min•Season 4Ep. 8
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
"I'll have what she's having." We'll take you through and discuss the recent release of Avidity Biosciences topline results from the phase 1/2 FORTITUDE trial and the preliminary data from the biomarker cohort extension.
For the best experience, listen in Metacast app for iOS or Android